Cell Therapy Technology Global Market Report 2022: Increasing Cell-Based Therapies Focused on Treating Cancer Drives Industry – ResearchAndMarkets.com

Dublin –(Business Wire)–“Cell Therapy Technology Market by Process, By Cell Type, By Product, By End User and By Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s supply.

The cell therapy technology market size is estimated at USD 14,532.1 million by 2021 and is expected to expand at a CAGR of 13.63% during the forecast period 2022-2029. Growing focus on cell-based therapies to treat cancer, technological development, substantial government funding for cell-based research, and product advancements are some of the key drivers for market growth. However, high price, low success rate, and lack of effective and efficient healthcare infrastructure for cell-based research are expected to restrain the market growth.

By process

On the basis of process, the market is segmented into cell preservation, distribution and handling, cell processing, and process monitoring and quality control. In 2021, the battery processing segment will account for the largest revenue share due to increased investment in research and development of battery manufacturing technologies.

by cell type

On the basis of cell type, the market is segmented into stem cells, T cells, and others. In the global market, the stem cell segment will account for the largest revenue share in 2021 owing to the development of innovative treatments for chronic diseases and the substantial increase in the number of applications of stem cells in the clinical setting.

By product

On the basis of product, the market is segmented into equipment, consumables, systems, and software. Consumables will account for the highest revenue share in 2021 due to increasing corporate investment in cutting-edge technology development and government initiatives to enhance cell-based research.

By end user

On the basis of end user, the market is segmented into research institutes and life science research companies. In 2021, the life sciences research companies segment will account for the largest revenue share owing to the massive adoption of cutting-edge tools in cell-based experiments and cancer research, as well as the growing number of global R&D facilities.

Regional Markets North America accounted for the highest revenue in the cell therapy technology market in 2021 and is expected to maintain its dominance over the forecast period. This is attributable to the increasing R&D efforts of the pharmaceutical and biotech industries and the increasing incidence of chronic diseases in the region. However, the Asia-Pacific region is expected to be the region with the greatest potential throughout the forecast period owing to increasing research investments in vaccine development.

Segmentation: Cell Therapy Technology Market Report Process 2021-2029 (Revenue, USD Million)

  • Cell preservation, distribution and handling

  • Cell processing

  • Process monitoring and quality control

Cell Type (Revenue, USD Million)

  • stem cell

  • T cells

  • other

Product (Revenue, $M)

  • equipment

  • consumables

  • Systems and Software

End Users (Revenue, USD Million)

  • Research institutes

  • Life Science Research Corporation

By Region (Revenue, USD Million)

North America


  • Germany

  • France

  • U.K.

  • Spain

  • Italy

  • Rest of Europe


  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia Pacific

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of Latin America

Middle East and Africa

  • South Africa

  • GCC

  • the rest of the MEA

Key topics covered:

1. Research methodology

2. Introduction: Cell Therapy Technology

3. Executive Summary

4. Market dynamics

5. Market environment analysis

6. COVID-19 Impact Analysis: Cell Therapy Technology Market

7. Market Analysis by Process

8. Market Analysis by Cell Type

9. Product market analysis

10. End User Market Analysis

11. Regional Market Analysis

12. North American cell therapy technology market

11. European Cell Therapy Technology Market

12. Asia-Pacific cell therapy technology market

13. Latin America Cell Therapy Technology Market

14. MEACell therapeutic technology market

15. Competitor Analysis

16. Company Profile

17. Conclusions and Recommendations

mentioned company

  • Merck & Co. (Germany)

  • Stem Cell Technology (Canada)

  • Miltenyi Biotechnology Co., Ltd. (Germany)

  • Danaher Corporation (USA)

  • TrakCel (UK)

  • FUJIFILM Irvine Scientific (USA)

  • Sartorius AG (Germany)

  • Biotechnology Company (US)

  • Terumo BCT (US)

  • flow cytometer

  • Dickinson Corporation (USA)

  • MAK System (US)

  • IxCells Biotechnology (China)

  • Fresenius SE & Co. KGaA (Germany)

  • Avantor Inc. (we)

  • Thermo Fisher Scientific (US)

  • Corning Incorporated (US)

  • Lonza Group (Switzerland)

  • Werum IT Solutions GmbH (Germany)

  • Rooster Bio, Inc. (US)

  • SIRION Biotech GmbH (Germany)

  • L7 Informatics Inc. (us)

  • GPI Iberia (Spain)

  • OrganaBio LLC (USA)

  • MaxCyte Inc. (us)

  • Wilson Wolf Manufacturing Company (USA)

For more information on this report, please visit https://www.researchandmarkets.com/r/y82l6u

Source link